Active ingredient: trastuzumab.
Dosage preparations: 150 mg single-dose vials, and 440 mg multidose vials containing powder for concentrate for solution for infusion. Reconstituted trastuzumab concentrate contains 21 mg/ml of trastuzumab.
Other Services
Country
Account